A detailed history of Assetmark, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Assetmark, Inc holds 46,316 shares of LLY stock, worth $40.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
46,316
Previous 42,961 7.81%
Holding current value
$40.6 Million
Previous $33.4 Million 25.47%
% of portfolio
0.13%
Previous 0.11%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $2.43 Million - $3.05 Million
3,355 Added 7.81%
46,316 $41.9 Million
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $1.52 Million - $2.03 Million
2,563 Added 6.34%
42,961 $33.4 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $573,507 - $676,089
1,092 Added 2.78%
40,398 $23.5 Million
Q3 2023

Oct 27, 2023

BUY
$434.7 - $599.3 $38,253 - $52,738
88 Added 0.22%
39,306 $21.1 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $1 Million - $1.34 Million
-2,857 Reduced 6.79%
39,218 $18.4 Million
Q1 2023

May 05, 2023

BUY
$310.63 - $364.82 $1.07 Million - $1.26 Million
3,445 Added 8.92%
42,075 $14.4 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $48.4 Million - $56.4 Million
-150,630 Reduced 79.59%
38,630 $14.1 Million
Q3 2022

Nov 01, 2022

BUY
$296.48 - $337.87 $4.89 Million - $5.57 Million
16,477 Added 9.54%
189,260 $61.2 Million
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $1.93 Million - $2.26 Million
6,911 Added 4.17%
172,783 $56 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $1.61 Million - $2 Million
6,857 Added 4.31%
165,872 $47.5 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1.4 Million - $1.74 Million
6,235 Added 4.08%
159,015 $43.9 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $1.16 Million - $1.43 Million
5,245 Added 3.56%
152,780 $35.3 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $33.1 Million - $42.8 Million
-183,289 Reduced 55.4%
147,535 $33.9 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $58.8 Million - $76.1 Million
-357,780 Reduced 51.96%
330,824 $61.8 Million
Q4 2020

Feb 10, 2021

BUY
$130.46 - $172.63 $8.78 Million - $11.6 Million
67,276 Added 10.83%
688,604 $116 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $14.2 Million - $16.4 Million
97,100 Added 18.52%
621,328 $92 Million
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $7.3 Million - $8.78 Million
53,497 Added 11.36%
524,228 $81.9 Million
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $5.49 Million - $6.8 Million
-46,135 Reduced 8.93%
470,731 $65.3 Million
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $3.91 Million - $4.84 Million
36,566 Added 7.61%
516,866 $67.9 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $7.47 Million - $8.13 Million
69,966 Added 17.05%
480,300 $53.7 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $5.55 Million - $6.48 Million
50,087 Added 13.9%
410,334 $45.5 Million
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $1.85 Million - $2.18 Million
16,632 Added 4.84%
360,247 $46.7 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $36.2 Million - $40.6 Million
342,113 Added 22777.16%
343,615 $39.8 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $25,414 - $31,763
-296 Reduced 16.46%
1,502 $161,000
Q2 2018

Aug 01, 2018

SELL
$75.7 - $86.88 $4,163 - $4,778
-55 Reduced 2.97%
1,798 $153,000
Q1 2018

May 16, 2018

SELL
$74.21 - $87.6 $462,402 - $545,835
-6,231 Reduced 77.08%
1,853 $143,000
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $253,194 - $271,580
-3,090 Reduced 27.65%
8,084 $683,000
Q3 2017

Nov 08, 2017

SELL
$77.07 - $85.54 $362,306 - $402,123
-4,701 Reduced 29.61%
11,174 $956,000
Q2 2017

Aug 15, 2017

BUY
N/A
2,962 Added 22.94%
15,875 $1.31 Million
Q1 2017

Sep 15, 2017

BUY
N/A
8,953 Added 226.09%
12,913 $1.09 Million
Q4 2016

Sep 15, 2017

SELL
N/A
-18,566 Reduced 82.42%
3,960 $291,000
Q3 2016

Sep 15, 2017

SELL
N/A
-2,598 Reduced 10.34%
22,526 $1.81 Million
Q2 2016

Sep 15, 2017

SELL
N/A
-3,294 Reduced 11.59%
25,124 $1.98 Million
Q1 2016

Sep 15, 2017

BUY
N/A
23,528 Added 481.15%
28,418 $2.05 Million
Q4 2015

Sep 15, 2017

BUY
N/A
4,890
4,890 $412,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.